Process analytical technology combines understanding and control of the process with real-time monitoring of critical quality and performance attributes. The goal is to ensure the quality of the final product. Currently, chromatographic processes in biopharmaceutical production are predominantly monitored with UV/Vis absorbance and a direct correlation with purity and quantity is limited. In this study, a chromatographic workstation was equipped with additional online sensors, such as multi-angle light scattering, refractive index, attenuated total reflection Fouriertransform infrared, and fluorescence spectroscopy. Models to predict quantity, host cell proteins (HCP), and double-stranded DNA (dsDNA) content simultaneously were developed and exemplified by a cation exchange capture step for fibroblast growth factor 2 expressed in Escherichia coliOnline data and corresponding offline data for product quantity and co-eluting impurities, such as dsDNA and HCP, were analyzed using boosted structured additive regression. Different sensor combinations were used to achieve the best prediction performance for each quality attribute. Quantity can be adequately predicted by applying a small predictor set of the typical chromatographic workstation sensor signals with a test error of 0.85 mg/ml (range in training data: 0.1-28 mg/ml). For HCP and dsDNA additional fluorescence and/or attenuated total reflection Fourier-transform infrared spectral information was important to achieve prediction errors of 200 (2-6579 ppm) and 340 ppm (8-3773 ppm), respectively. 
| INTRODUCTION
Real-time monitoring and model-based prediction of purity and quantity are key steps towards real-time release in the manufacturing of biopharmaceuticals (Jiang et al., 2017) . According to the ICH guidelines (Q8 R2), real-time release testing is defined as "the ability to evaluate and ensure the quality of an in-process and/or final drug product based on process data, which typically includes a valid combination of measured material attributes and process controls" (Holm, Allesø, Bryder, & Holm, 2017) . There is not a single online sensor available that allows a direct measurement of the quality of a biopharmaceutical. Therefore, the information must be extracted from multiple sensor signals. In addition, model-based prediction of purity and quantity can be used for process control, in particular for real-time decisions on pooling. Currently, the determination of the critical quality attributes (CQAs) of biopharmaceutical products during processing is performed offline after the unit operation has been completed. This requires extensive sample preparation, is timeconsuming, and adds to the manufacturing costs. The acquired information is available with a substantial time delay. Such a Quality-by-Testing approach using offline analysis is a retrospective quality control and is not suitable for continuous manufacturing (Food & Drug Administration, 2004; Löfgren et al., 2017) . In contrast, the fundamental concept of the Quality-by-Design (QbD) approach is that a process is controlled to perform in defined design space and thus guarantees a continuous quality output (Rathore, 2016; Read et al., 2010; Scott & Wilcock, 2006; Yu et al., 2014) . Process analytical technology (PAT), as one strategy of the QbD approach, includes the tasks of designing, analyzing and controlling production processes based on real-time monitoring of quality attributes to allow continuous manufacturing and enhanced flexibility. Online monitoring by employing fast and noninvasive mostly spectroscopic technologies collect real-time data of the process which have to be converted into relevant process information by appropriate statistical models. Therefore, online monitoring and model predictive control are mandatory for the realization of a PAT approach and to significantly reduce the need for offline analyses. Besides process control, PAT can be applied efficiently to increase the process understanding during development (Rathore, 2016) and for prospective real-time release (Jiang et al., 2017) . So far, QbD and PAT have limited applications in biomanufacturing. Several studies for real-time monitoring of upstream processes were performed where the most important criteria to be controlled are the product formation and feed strategies and corresponding offline methods (e.g., cell-based assays) can last up to days (Dabros, Amrhein, Bonvin, Marison, & von Stockar, 2009; Luchner et al., 2012; Melcher et al., 2015; Melcher, Scharl, Luchner, Striedner, & Leisch, 2017; Pais, Carrondo, Alves, & Teixeira, 2014; von Stosch, Hamelink, & Oliveira, 2016) . Chromatography is the main purification method for biopharmaceutical proteins. Process-related impurities such as host cell proteins (HCP), DNA, endotoxins, and product-related impurities (e.g., product variants or aggregates) have to be depleted to deliver a product that meets defined quality standards (Food & Drug Administration, 2003) . Controlled loading and pooling of the eluates are critical for the overall chromatography performance to ensure consistent product quality (Borg et al., 2014) . The knowledge of the eluate composition is crucial for subsequent downstream steps.
Currently, process decisions are based mainly on online monitoring of UV absorbance, which is beneficial for the estimation of overall protein content or the protein/DNA ratio, but is rather unspecific for typical co-eluting critical impurities. It is challenging when HCP and product variants possess physicochemical properties similar to the target protein. For reliable control of preparative chromatographic processes, monitoring methods have to discriminate the product from relevant impurities within short response times (i.e. seconds), as quality attributes of the effluent are changing quickly. Another challenge is the complex matrix of buffers and product samples that change throughout the purification steps. Single sensor methods have been examined for their feasibility in PAT for pooling of chromatographic methods (Großhans et al., 2018; Rathore, Li, Bartkowski, Sharma, & Lu, 2009; Rathore, Wood, Sharma, & Dermawan, 2008; Rathore, Yu, Yeboah, & Sharma, 2008; Read et al., 2010; Rüdt, Briskot, & Hubbuch, 2017) . Most commonly, UV/Vis absorption and attenuated total reflection Fouriertransform infrared (ATR-FTIR) spectroscopy are used for PAT applications (Brestrich, Briskot, Osberghaus, & Hubbuch, 2014; Brestrich et al., 2015; Großhans et al., 2018; . In all these cases, only a single quality attribute was monitored and used as a pooling criterion. Spectroscopic methods have been widely used as tools, as they deliver information on the primary, secondary, tertiary, and quaternary structures of proteins. These techniques are useful as noninvasive, nondestructive, rapid, sensitive, and automatable methods with the ability to provide information simultaneously on different proteins, conformational variations, or DNA (Brestrich et al., 2014; Flatman, Alam, Gerard, & Mussa, 2007; Workman, Koch, & Veltkamp, 2007) . UV/Vis spectroscopy mainly measures the primary structure, such as the content of aromatic amino acids (UV 280 nm ) or polypeptide backbone (UV 214 nm ). The UV 260 nm absorbance provides an estimation of DNA content (Antosiewicz & Shugar, 2016) . The refractive index (RI) has also been applied for protein quantification (Zhao, Brown, & Schuck, 2011) . The secondary structure can be measured by vibrational spectroscopy such as FTIR, circular dichroism, and Raman spectroscopy (Flatman et al., 2007; Rüdt, Briskot et al., 2017; Workman et al., 2007) . At-line ATR-FTIR can distinguish between HCP and target protein . The benefit of ATR is the lack of complex sample preparation, as part of the totally reflected infrared beam in the ATR crystal enters the sample interface. In the spectral regions where the sample absorbs energy, the beam is attenuated (Barth, 2007) . The tertiary structure of proteins can be measured via intrinsic fluorescence of the aromatic amino acids and structural changes induced by polarity changes can be detected (Ghisaidoobe & Chung, 2014; Rathore et al., 2009 ). Their quaternary structure, for example, protein aggregation, can be determined by light scattering methods (Lorber, Fischer, Bailly, Roy, & Kern, 2012; Minton, 2016) . Fluorescence spectroscopy, as well as light scattering techniques, have been used for at-line determination of quality attributes (Rathore et al., 2009; Yu, Reid, & Yang, 2013) . All those spectroscopic data are complex with limited first principle knowledge. Online ion-exchange liquid chromatography has been applied to monitor antibody variants in a continuous process, however one sample measurement lasts 15 min (Patel et al., 2017) .
State of the art statistical methods to relate many sensor signals to offline analyses include Partial Least Squares (PLS), tree-based methods (e.g., Random Forests) or boosted structured additive regression (STAR), which extends the well-known multiple linear regression models with interaction effects or nonlinear spline functions (Bühlmann & Hothorn, 2007; Hothorn, Bühlmann, Kneib, Schmid & Hofner, 2015) .
No studies are available using a combination of sensors that would allow the simultaneous monitoring and prediction of many product quality attributes in parallel (Borg et al., 2014; Großhans et al., 2018; Rathore et al., 2009; Rüdt, Brestrich, Rolinger, & Hubbuch, 2017; Rüdt, Briskot et al., 2017; von Stosch et al., 2016; Yu et al., 2013) .
The aim of the present study was a comprehensive and efficient real-time monitoring of a protein purification step using a panel of online sensors. UV/Vis, pH and conductivity probes are standard sensors of a chromatographic workstation. Multi-angle light scattering (MALS) and RI detectors, ATR-FTIR, and fluorescence spectroscopic sensors were additionally integrated into a commercially available chromatographic workstation for model-based prediction of product quantity and impurity content. As HCP and dsDNA are critical host cell impurities they were addressed in this study. Data analysis was performed with boosted STAR, which gives promising results in settings, where the number of variables (greatly) exceeds the number of observations, as it is common, when spectroscopic sensor systems are involved (Melcher et al., 2017) .
| MATERIALS AND METHODS

| Fibroblast growth factor 2
Fibroblast growth factor 2 (FGF-2) was overexpressed in Escherichia coli (E. coli) BL21 cells (Sauer et al., 2018) . FGF-2 has a molecular weight of 17 kDa and an isoelectric point pI of 9.6 (Gasparian et al., 2009 ).
| Chromatographic capture step by ion exchange
A cation exchange resin was used to purify FGF-2 from the clarified E. coli homogenate. A Tricorn column (d = 10 mm; h = 150 mm; GE Healthcare; Uppsala, Sweden) was packed with Carboxymethyl Sepharose Fast Flow resin (GE Healthcare; Uppsala, Sweden) resulting in a column volume (CV) of 11.8 ml. The FGF-2 capture method was conducted at a flow rate of 1 ml/min. 10 CV of clarified E. coli homogenate (1.7 ± 0.2 mg/ml) were loaded and elution was performed with a linear gradient from 0 to 1 M NaCl in 100 mM Naphosphate (pH 7.0). For each performed chromatographic run, 15 fractions (UV 280 nm signal >50 mAU) of 1 ml were collected and used for all offline assays (Sauer et al., 2018) . Clarified homogenate compositions of fermentation batches are provided in Table SI .
| Offline monitoring
Product quantity (mg/ml) was determined by reverse-phase highperformance liquid chromatography (RP-HPLC). Based on the FGF-2 concentration, the relative dsDNA content (ppm) was quantified by PicoGreen ® assay and the HCP content (ppm) by enzyme-linked immunosorbent assay (ELISA). The intra-assay variabilities were 20%
for HCP ELISA, 15% for the PicoGreen ® assay, and 5% for the RP-HPLC quantification (Sauer et al., 2018) .
| Online monitoring
The chromatographic 
| Data preprocessing and statistical modeling
On-and offline data were collected for 19 chromatographic runs, 13 of which were used for model building (training runs) and the remaining six served as test runs. All runs were performed under identical experimental conditions and are expected to differ only by random, biological variation. The test runs originate from two SAUER ET AL.
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different fermentation batches and therefore represent a typical field of application of the derived models. While the test runs are complete data sets, there are some missing sensor data in the training set.
The major preprocessing operations consisted of two timealignment steps:
(1) The correction of the time shift in the data between the online sensors resulting from void volumes in the setup. The delay volume between the first (UV) and last sensor (RI) was 1.39 ml and between the last sensor and the outlet valve 0.37 ml.
(2) Offline data were available for 1 ml fractions (collection time: technique (Fahrmeir, Kneib, & Lang, 2004) . Based on a n p × predictor matrix X with entries x ij and a n−vector of responses y, a response value y i is modeled with univariate linear (f j lin ) or smooth terms (e.g., spline functions f j s ) and (eventually) bivariate interaction terms f j ia resulting in the following model:
The sums extend over predictors (or pairs of predictors in the interaction case) and i ε is a random error term capturing the unexplained variation in the data. Due to computational reasons, besides linear and penalized regression (P-) splines (Eilers & Marx, 1996) only product interactions between non-spectroscopic pre- baselearners with m (the number of iterations) usually being determined by a form of cross-validation (Bühlmann & Hothorn, 2007; Bühlmann & Yu, 2003) . Typically, between a few hundred up to several thousand iterations are required. This model optimization is performed on the training set using leave-one-run-out cross-validation, that is a model is built on all observations except those from a single run and applied to the left-out observations. This process is repeated until each run was left out once. As an error measure, the root-mean-square error is chosen:
where n is the number of observations, y i the measured and y î the predicted response. If the predictions y î in equation (2) 
All computations were performed using the software platform R version 3.4.2 (R Core Team, ) using the packages mboost (Hofner, Boccuto, & Göker, 2015; Hofner, Hothorn, Kneib, & Schmid, 2011; Hothorn et al., 2015) , signal and baseline.
| RESULTS
The model building workflow is depicted in Figure 1 . Standard signals from sensors of the chromatographic workstation (UV 280 nm , UV 260 nm , UV 214 nm, pH, conductivity) were complemented with MALS, RI, fluorescence spectroscopy, and ATR-FTIR (Figure 1a -e).
The clarified E.coli homogenate was loaded on a CM-Sepharose Fast By using a stepwise approach (basic → medium → extensive model) the benefit of a sensor system for predicting a response can be assessed by comparing the RMSE CV values for models with or without this sensor type. A more complex model (with respect to the number of sensors and/or predictors) is considered as superior only if a considerable reduction in RMSE CV is achieved which compensates the loss in robustness (due to missing data extensive models can only be based on 7 instead of 13 runs as for the basic and medium models) and the higher computational costs.
| Prediction of FGF-2 quantity
Already the basic model enables an accurate prediction of the product quantity with a RMSE CV of 0.51 mg/ml (range in training data: 0.1-28 mg/ml), which corresponds to a relative error of predictors (UV and conductivity) is preferred.
In our purification process, a low HCP content of <20 ppm was reached in the fractions of the highest FGF-2 concentration and up to 6500 ppm in later eluting fractions. Therefore, the unspecific influence and contribution of HCP to the UV absorbance was not significant. For purification protocols, where a higher content of coeluting impurities will be present, models including MALS, RI, ATR-FTIR, or fluorescence signals are expected to be superior over the basic model. 
| Prediction of HCP content
Basic and medium models for HCP content show similar prediction errors of 563 and 582 ppm, respectively, and hence no benefit of the MALS and RI sensors is determined (Figure 3a) . Accurate prediction of HCP requires spectroscopic sensors, which becomes evident in The choice between the more robust and parsimonious basic model and a more complex extensive model, which outperforms the former on the 7-run data set, is somewhat subjective. However, Figure 4c shows exemplarily the performance of the extensive model contain- However, in the case of dsDNA, the overall errors (both crossvalidated and test errors) were significantly lower for models based on the original response data. The benefit of the sensors for dsDNA quantification is lower than for protein-based information.
| Process control -model-based pooling
After integration into the chromatographic system, these models can be used in process control as a PAT application and enable predictions of the quality attributes in real-time, which is the overall goal of the online monitoring system. The methodology presented can be used for online pooling by switching the collection valve, for decisions if the process stream is out of specification or for a 
| DISCUSSION
Our study demonstrates that the selected analytical spectroscopic methods provide a promising sensor combination for simultaneous determination of several biopharmaceutical quality attributes. By applying the final models (Table 2) components give signals in certain regions of the ATR-FTIR spectra Rathore et al., 2009 ).
Usually, the buffer background is subtracted before the spectrum is deconvoluted. This is not possible with a linear gradient or suitable for real-time monitoring. We circumvented this problem by using preprocessing operations such as spectra differences and normalization. For spectroscopic data evaluation, statistical models are especially useful to extract information as spectral overlaps of matrix background and analytes are common (Esmonde-White, Cuellar, Uerpmann, Lenain, & Lewis, 2017) . The models established in our setup will be valid for minor process deviations as they have been verified with the independent test runs. The process variability represented in the training set defines the model applicability (Esmonde-White et al., 2017) . Therefore transferability of the models to other processes relies on measured data in the training set (Craven, Shirsat, Whelan, & Glennon, 2013; Kroll, Hofer, Ulonska, Kager, & Herwig, 2017; Pernot, 2017) . The established methodology allows simultaneous real-time prediction of quantity, HCP, and dsDNA. This attempt will be a basis for process control and realtime release. This real-time monitoring approach requires the cooperation of several disciplines: data science, biotechnology, biophysics, and software engineering. More work like the prediction of product potency is required to reach real-time release requirements as end-product testing cannot be replaced so far, but already in-process offline testing can be reduced and real-time control can be conducted for process consistency.
| CONCLUSION
Real-time monitoring of a chromatographic capture step was successfully implemented and provided a model-based prediction of HCP and dsDNA content and quantity of a biopharmaceutical.
STAR modeling can be applied for the prediction of (critical) quality attributes in the eluate within seconds, despite the coelution of many protein and non-protein impurities. A small set of online signals from the chromatographic workstation enabled the adequate prediction of protein quantity. However, the prediction of HCP and dsDNA content demanded more complex models including spectroscopic sensors. The online sensors setup and the predictive models are the basis for real-time interventions, either for process control (e.g., pooling) or real-time release. In chromatography, the production efficiency, yield, and product quality can be improved and time-consuming offline analyses are reduced. Our findings pave the way towards PAT implementation in biopharmaceutical manufacturing. were achieved using the Vienna Scientific Cluster (VSC).
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